PDCD1 and cervical cancer: The Anti-PD-1, TSR-042, as Maintenance Therapy for Patients with High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) trial is a phase II trial using anti PD-1, TSR-042 as consolidation therapy post standard CRT (Table 2) (34).